Form 4: Royalty Pharma Director Acquires Shares in Lieu of Quarterly Retainer

Director Henry A. Fernandez acquired 1,399 Class A Ordinary Shares of Royalty Pharma plc (RPRX) on June 28, 2024, in lieu of a quarterly retainer payment.

Summary

• On June 28, 2024, Henry A. Fernandez, a director of Royalty Pharma plc (RPRX), acquired 1,399 Class A Ordinary Shares.
• The shares were acquired at a price of $26.7998 per share.
• This acquisition was made in lieu of a quarterly retainer payment of $37,500 under the Issuer's 2020 Independent Director Equity Incentive Plan.
• Following the transaction, Fernandez directly owns 52,660 Class A Ordinary Shares.
• Fernandez also indirectly owns 58,200 Class A Ordinary Shares through the Fernandez 2007 Children's Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. A director acquiring shares is generally a good sign, indicating confidence in the company's future. The transaction itself is routine and expected.

Positives

• The director's acquisition of shares demonstrates confidence in the company.
• The equity incentive plan aligns the director's interests with those of the shareholders.

Industry Context

Director share acquisitions are common and often viewed positively as they align management's interests with shareholders. The use of equity in lieu of cash compensation is also a common practice to conserve cash and incentivize performance.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the pharmaceutical and biotech industries.
• Companies like Amgen, Gilead Sciences, and Johnson & Johnson also utilize equity-based compensation plans for their directors.
• The amount of equity granted in lieu of cash retainers is generally comparable to industry averages for companies of similar size and market capitalization.

Stakeholder Impact

• The share acquisition could have a slightly positive impact on shareholder sentiment.
• The use of equity instead of cash for director compensation benefits the company's cash flow.

Key Dates